Phase III trial data published in The New England Journal of Medicine support Nucala’s role as an add-on biologic therapy to ...

Joshua Bastean got some food caught in his esophagus. Having to call for help, his mom needed to regurgitate the stuck food ...

May has just begun, and it's time to turn our attention to the FDA decisions on deck for the coming weeks.So far this year, the U.S. regulatory agency has approved only ...

Phathom Pharmaceuticals, Inc.’s PHAT share price has dipped by 19.35%, which has investors questioning if this is right time ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

Adults with eosinophilic esophagitis may have elevated levels of multiple food allergen–specific antibody types other than ...

Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis ...

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Eosinophilic Esophagitis ORLANDO, FLORIDA / ACCESS Newswire / April 28, 2025 / The Assistance Fund, an independe ...

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Eosinophilic Esophagitis ORLANDO, FLORIDA / ACCESS Newswire / April 28, 2025 / The Assistance Fund, an ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

Eupraxia's CEO, Dr. James Helliwell, will be presenting on May 5th, 2025, at 3:30pm ET at the Bloom Burton & Co. Healthcare Investor Conference being held at the Metro Toronto Convention Centre, and ...

The National Institutes of Health has withdrawn renewal grant applications for the Consortium of Eosinophilic Gastrointestinal Disease Researchers. Patient advocacy organizations, including the ...